Australian device reporting taps into pharmacies:
This article was originally published in Clinica
Executive Summary
The increasing number of medical devices which are supplied through pharmacy-type outlets has prompted Australia's Therapeutic Devices Branch to distribute therapeutic device adverse incident reporting forms with the Schedule of Pharmaceutical Benefits. The Schedule is sent to around 45,000 pharmacists, doctors and hospital dispensaries throughout Australia. "Pharmacists are becoming a key link in ensuring the safe supply of many over-the-counter therapeutic devices," says the Australian Therapeutic Device Bulletin. These include dental products, syringes, catheters, condoms, contraceptive diaphragms, hearing aids, nebulisers, blood pressure monitors and diagnostic kits.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.